A B S T R A C T While 3,3',5'-triiodothyronine (reverse TS, rTs) has been detected both in human serum and in thyroglobulin, no quantitative assessment of its metabolic clearance rate (MCR), production rate (PR), or secretion by the thyroid is yet available. This study examines this information in euthyroid subjects and evaluates it in light of similar information about two other iodothyronines in the thyroid: 3,5,3'-triiodothyronine (Ta) and thyroxine (T4). Thus, it was noted that rTs is cleared from human serum at a much faster rate than are Ts and T4; the mean (±-SE) MCR of rT3 was 76.7±5.4 liters/day in 10 subjects, whereas MCR-T3 and MCR-T4 in 8 of them were 26.0±2.2 liters/day and 1.02±0.06 liters/day, respectively. Therefore, even though the mean serum concentration of rT3, 48+2.8 ng/ 100 ml, was much lower than that (128±6.7 ng/100 ml) of T3, the mean PR-rTs (36.5+2.8 ,ug/day) and the mean PR-T3 (33.5±3.7 Ag/day) were similar; in comparison, the mean serum concentration and PR of T4 were 8.6± 0.5 ,ug/100 ml and 87.0±3.9 Mg/day, respectively. These data and those on the relative proportion of rT3, T3, and Ts in 10 thyroid glands were used to assess the significance of the contribution of thyroidal secretion to PRrTs and PR-Ta. It was estimated that whereas thyroidal secretion may account for about 23.8% of serum T3 (or PR-Ta), it may account for only about 2.5% of serum rTa (or PR-rTs). Since peripheral metabolism of T4 is the only known source of rT3 and Ta other than the thyroidal secretion, it could be calculated that as much as 73.0 Ag or 84% of daily PR-T4 may normally be metabolized by monodeiodination either to T3 or to rT3.
INTRODUCTION
Like 3,5,3'-triiodothyronine (Ta),' 3,3',5'-triiodothyronine (reverse Ta, rTa) has recently been identified in human thyroglobulin and in serum of hypothyroid patients and euthyroid subjects receiving treatment with thyroxine (T4) (1, 2) . While considerable data are available in case of T3 (3) (4) (5) (6) , there is a paucity of information about the kinetics of peripheral metabolism and the daily 'Abbresiations used in this paper: MCR(s), metabolic clearance rate(s); PR(s), production rate(s); reverse T8, rT3, 3,3',5'-triiodothyronine; T2, 3,3'-L-diiodothyronine; T3, 3,5,3'-triiodothyronine; T4, thyroxine; TCA, trichloroacetic acid.
The Journal of Clinical Investigation Volume 58 July 1976- [32] [33] [34] [35] [36] [37] [38] [39] [40] turnover rate of reverse T3. Similarly, little information is available regarding the relative significance of the contribution of the thyroidal secretion and the peripheral metabolism of T4 to serum rTa in man. The studies to be described were undertaken to gather information pertaining to these issues and to estimate the extent to which T4 may normally be metabolized by monodeiodination either to Ts or to reverse T3. Additionally, it has recently been reported that serum rT3 levels may be increased in several situations, e.g., the fetus and the newborn and a variety of systemic illnesses, protein-calorie malnutrition and starvation, where serum concentration and(or) daily production rate of T3 may be decreased (1, 2, (7) (8) (9) . In the present study, an attempt has been made to investigate the changes in relative metabolic clearance rates and production rates of T4, T3, and rT3 in one such situation, i.e., hepatic cirrhosis, where serum T3 and rT3 may vary in opposite directions.
METHODS
Subjects. Studies were conducted in 15 volunteer subjects, 10 of whom (6 men and 4 women, 1941-yr-old) were euthyroid healthy subjects and 5 of whom (3 men and 2 women, 35-66-yr-old) were patients with hepatic cirrhosis. The patients with hepatic cirrhosis had a history of chronic alcohol abuse and had presented with clear evidence of chronic liver disfunction. All patients had icterus, spider angiomata, palmar erythema, hepatomegaly, and edema and (or) ascites; their liver function tests revealed decreased serum albumin, elevated serum bilirubin, transaminase, and alkaline phosphate levels, and subnormal proithrombin time. Liver biopsy was performed at a previous hospitalization in four of five cases; histology was consistent with the diagnosis of hepatic cirrhosis in each of these cases. Hepatic scintiscan supported the clinical diagnosis of cirrhosis and portal hypertension in the remaining case.
Hormonal measurements. Serum concentrations of rT3, T3, and T4 were measured by radioimmunoassays described previously (1, 10, 11 not be studied similarly by using anti-T4, because the available anti-T4 was prepared by immunization of rabbits with thyroglobulin, which, besides T4, also contained rT3; previous studies had revealed the presence of significant concentrations of rT3 binding sites in the available anti-T4. The composition of ['I] rT3 was also studied by paper chromatography for 16 h at 37°C using hexane, tertiary amyl alcohol, and 2 N ammonium hydroxide (vol/vol, 1: 5: 6); rT3, T4, and T3 were separated quite clearly by this procedure. However, radioautography of the paper chromatogram revealed only one band of radioactivity corresponding to the rT3 region. Besides other iodothyronines, radioiodide could be another contaminant of radioactive rT3 as well as of radioactive iodothyronines studied. However, the effect of any radioiodide contaminating labeled iodothyronines on the kinetics of iodothyronines would be minimized by the technique used for processing of specimens (vide infra). Thyroid glands. Thyroid glands were obtained at the time of autopsy of 10 apparently euthyroid subjects. Thyroid glands were homogenized, and an aliquot hydrolyzed with Pronase (Calbiochem, La Jolla, Calif.) under previously described conditions (17, 18) . The hydrolysates were extracted with 2 volumes of 95% ethanol and rT3, T3, and T4 were determined by radioimmunoassays as described previously (1, 18, 19) . RESULTS
Radioactive iodothyronines in serum of euthyroid subjects. To compare the efficiency of TCA precipitation and ethanol extraction of various iodothyronines from serum, about 10,000 cpm of radioactive rTs, T3, and T4 were added to 0.5 ml-aliquots of four sera and sera were processed as described above in the Methods. TCA precipitates contained 88.2+0.6%2 of rT3, 86.8+0.60% of T3 and 90.5±0.74% of T4. The fraction of rTs and Ts precipitated by TCA were similar but both of these values were modestly lower than that in case of T4 (P < 0.05). The radioactivity remaining in the precipitate after ethanol-extraction was 1.2±0.03% for rTs, 2 however, higher than those of rTs and T3 (P < 0.05). These studies indicated that TCA precipitation and ethanol extraction of various iodothyronines yields results which are similar but not identical. Therefore, with a view to minimize the effects of these (albeit small) differences in extractability of iodothyronines on kinetic studies, the standards were processed in a manner identical to that employed for the test specimens. The relative rates of disappearance from serum of TCA-precipitable and ethanol-extractable radioactivity, presumably representing the iodothyronines, after injection of radioactive rT3, T3, and T4 are shown in Fig.  1 ; the data on the mean percent of dose per liter of serum of various iodothyronines have been plotted against time on a semilogarithmic plot. Reverse T3 disappeared from serum at a much faster rate than did T3 and T4; more than 98% of radioactive rT3 left the serum by 5 h of the injection of radioactive rT3.
Urine studies. Urinary excretion of radioactivity was e:camined in two cases given radioactive rT3. The radioactivity excreted in urine was 40 1 Disappearance from serum of TCA-precipitable and ethanol-extractable radioactivity, presumably representing iodothyronines, after injection of radioactive rT3, T3, and T4 intravenously to euthyroid subjects; the data on mean+SE and the percent dose per liter are plotted against time in hours on a semilogarithmic plot. excreted in urine during the first 24 h after injection of radioactive Ta was 32.6 and 32.8%, respectively in two cases. Urinary excretion of radioactivity was measured in four cases after injection of radioactive T4; the values at 24 h varied between 5.1 and 8.7% (mean, 6.9%). To examine whether the radioactivity excreted in urine after injection of radioactive rTs or Ts represented intact hormone or its metabolic product, e.g., radioiodide, aliquots of urine were mixed with an equal volume of pooled normal serum, incubated for 30 min at room temperature, and precipitated with 10% TCA to separate protein-bound radioactivity. Less than 5% of radioactivity could be recovered in the precipitate in each case studied and the remaining (over 95%) remained in the supernate. These findings suggested that urinary radioactivity was probably merely a degradation product and not the intact hormone per se.
MCRs and PRs of thyroid hormones in euthyroid man. The data on serum concentration, MCR, and PR of rT3, T3, and T4 in euthyroid subjects under study are presented in Table I 33.5 pg/day (range, 22.5-52.9). The mean serum concentration of T4 was 8.6 iAg/lOO ml (range, 7.2-12), whereas the mean MCR was 1.02 liters day (range, 0.69 to 1.29) , and the mean PR was 87 ug/day (range, 75.2-106).
Relative proportions of rTs, Ts, and T4 in the thyroid. To assess the significance of the thyroidal secretion of rTa and T3 relative to T4 in euthyroid man, the relative proportions of rTa, T3, and T4 were examined in homogenates of 10 thyroid glands. The mean T4 content of the thyroid was found to be 351.5±48.1 ug/g wet weight.
The mean molar ratio of the contents of T4 and rTa (T4/ rT3) was 75.5+0.10 (range, 33.5-121.6) and the mean molar ratio of the contents of T4 and Ts (T4/Ts) was 9.3±0.66 (range, 6.7-13.0).
Thyroidal contribution to serum concentration (or daily PR) of rTs and Ts. The significance of the contribution of thyroidal rTs secretion to PR-rTs in euthyroid man was assessed by estimating the approximate thyroidal contribution by using the data on MCR-rT3, MCR-T4, serum T4, and rTs/T4 ratio in the thyroid in calculations similar to those described previously for Ts (20, 21) ; it was assumed in these calculations that rTs and T4 are secreted in the proportions in which they exist in the thyroid. These calculations suggest that thyroidal secretion which results in a mean serum T4 of 8.6 ,g/l00 ml in euthyroid man (Table I ) adds only 1.2 ng/100 ml to rT8 in serum (or 0.92 ug/day to PR-rTs); 1. 1. Chopra this amount of rTs is only about 2.5% of that (48 ng/100 ml) actually measured in serum. These analyses suggest that the bulk, as much as 97.5% (100 -2.5 = 97.5) of serum rTa, derives from peripheral metabolism of T4.
The significance of the contribution of thyroidal T3 secretion to PR-T3 in euthyroid man was assessed by using the data on MCR-Ts, MCR-T4, serum T4, and Ta/T4 in the thyroid in calculations similar to those used for rTs. The calculations suggest that thyroidal secretion which results in a mean serum T4 of 8.6 lAg/100 ml may add about 30.4 ng T3 to 100 ml of serum (or 7.9 ig/day to PR-T8); this amount of T3 is about 23.8% of that (128 ng/100 ml) actually measured in serum. These analyses suggest that majority of Ts in serum, about 76.2% (100 -23.8 = 76.2), derives from peripheral metabolism of T4.
Metabolism of T4 by monodeiodination. From data on daily PRs of rT3, T3, and T4 in euthyroid man (Table I) and the assessment of thyroidal secretion of rT3 and T3, the amount of T4 metabolized by monodeiodination either to rTs or to T3 were estimated. MCRs and PRs of thyroid hormones in hepatic cirrhosis. The data on serum concentration and MCR and PR of rT3, Ts, and T4 in five cases with hepatic cirrhosis are shown in Table II . The mean serum rT3 concentration (81 vs. 48 ng/100 ml, P < 0.001) in these cases was clearly higher, whereas the mean serum Ta (39 vs. 128 ng/100 ml, P < 0.001) and the mean serum T4 (5.6 vs. 8.6 ug/100 ml, P < 0.001) were clearly lower than the corresponding value in normal subjects. 87.0 Fg/day, P <0.025) were significantly lower than the corresponding normal value. An examination of the relationship between PRs of rT3, T8, and T4 in hepatic cirrhosis is presented in" Fig. 2 .
The mean molar ratio of PR-rT3 and PR-T4 (rT3/T4) of 0.59+0.07 in hepatic cirrhosis patients was similar to that (0.54±0.03) in normal subjects. On the other hand, the mean molar ratio of PR-T3 and PR-T4 (T3/T4) of 0.18±0.04 was significantly (P < 0.005) lower than that (0.40+0.04) in normal subjects. The mean molar ratio of PR-rT3 and PR-T3 (rT3/Ta) of 3.95+0.95 was much higher than that (1.19+0.19) in normal subjects (P < 0.02).
DISCUSSION
The present study indicates that daily PR of rTa (36.5 Ag/day) may normally be equal to or more than that of Ts (33.5 Atg/day). There are no other data available at present to compare with the PR-rTs observed in this study. However, some information is available on two individual components of PR-rT3, i.e., serum concentration and MCR. Thus, serum concentrations of rT, similar to those measured in this study have also been observed by a different radioimmunoassay (2) . Furthermore, the rate of disappearance of radioactive rT3 in man has been examined in a previous study (22) . The data were similar to those reported here in indicating that rT3 disappears very rapidly from human circulation and that most ( > 50%) of the radioactivity administered appears as iodide in urine within 24 h of the injection (22) . However, quantitative assessment of MCR of rTs has not been reported in this (or any other) previous study. Calculation of MCR has been conducted in this study by an integral noncompartmental approach which is considered more appropriate for measurement of MCR of rapidly disappearing iodothyronines than the conventional single-compartmental technique (14) (15) (16) . Some assessment of the validity of measurements of MCR-rT3 is also provided by the data on MCR of other, extensively studied, iodothyronines, Ti and T3; these data were obtained by methods similar to those used for MCR of rT3. Thus, the mean normal MCR of T4, 1.02 liters/day, and mean normal MCR-T3, 26.0 liters/day, observed in this study are quite similar to those (22-27 liters/day for T3 and 1.0-1.3 liters/day for T4) observed in previous studies that used various different techniques for measurement of MCR but where the possibility of incorporation of radioactive hormone into iodoproteins was taken into account (4-6, 16, 23-25) . In addition to MCRs and PRs, the present study has examined the contribution of thyroidal secretion to PR of rT3 and T3. Thus, it appears that whereas thyroidal secretion may contribute about 23.8% of T3 produced daily, it contributes only about 2.5% of rTs produced daily.
Furthermore, since 3,3'-Ta cross reacts significantly in rT3 radioimmunoassay (1) and since the possibility that 3,3'-T2 may be secreted by the thyroid cannot be excluded, it seems possible that even the present low estimate of contribution of thyroidal secretion to PR-rTs (2.5%) may be an overestimate. Meanwhile, since thyroidal secretion and peripheral metabolism of T4 are the only two known sources of rT3 and Ta (1, 2) , the present study suggests that about 76.2% of PR-T3 and 97.5% of PR-rT3 may be derived from peripheral monodeiodination of T4. These estimates must, however, be considered approximations because: (a) the calculations have been based on mean values of various parameters, and appreciable variations were evident in individual cases in each of the various parameters of study; (b) multiple measurements are required to arrive at above estimates, and each measurement, although reasonably accurate, is not flawless; (c) the data on relative proportions of iodothyronines in the thyroid gland and those on kinetics of various iodothyronines had to be obtained in different subjects; and (d) it is assumed in above calculations that rTs, Ts, and T4 are secreted in the proportions in which they exist in the thyroid; the estimates of the significance of thyroidal secretion would have to be modified if subsequent studies were to show that T3 and(or) rTs are secreted preferentially. In any case, while there are these limitations, there are also reasons to consider the above estimates of relative contributions of thyroidal secretion and T4 metabolism to PR-T3-and PR-rTs sufficiently reliable to allow deduction as to the routes of metabolism of T4. Thus, the significance of the contribution of the peripheral metabolism of T4 to PR-T3 has been evaluated in several studies using different methods (5, 15, 20, 26, 27) , and in each case it has been estimated that peripheral conversion of T4 to T3 may contribute about 22-24 ig of Ts. Since recent studies using Ts radioimmunoassay indicate that daily euthyroid PR-Ts may only be about 28-36 'g/day (6, 28) the results of the present study agree with the previous studies in indicating that peripheral metabolism of T4 must normally be a major source of T3; studies in sheep have also led to a similar conclusion (29) .
Little information is currently available about the contribution of thyroidal secretion or peripheral metabolism of T4 to PR-rT3. However, the findings that serum rT3 concentrations in subjects receiving exogenous T4 are similar to or higher than those in normal subjects (1, 2) suggests that T4 metabolism must be a major source of rT3. Furthermore, previous studies (7) indicating that administration of thyrotropin results in little or no increase in serum rT3 at a time when serum Ts and T4 are increased suggest that thyroidal secretion must normally be a poor source of rT3. Additionally, detailed studies in sheep have provided data that agree with those in this study by indicating that thyroidal secretion may contribute rT3 only to an extent of about 3% of daily PR-rTs (8) .
Several previous studies suggest that about 85% of T4 produced daily is metabolized by deiodination (26, (30) (31) (32) (33) ; the rest is apparently lost as T4 or its conjugates (32) or is metabolized by deamination and decarboxylation of alanine side chain to tetraiodothyroacetic acid (34) . It has also been demonstrated that deiodination of T4 can occur both in the phenolic and in the tyrosyl ring of the T4 molecule (1, 35) . The present study suggests that the majority of T4 metabolized daily is monodeiodinated either to T3 or rT3; thus, one can account for almost 84% of daily PR-T4 as being monodeiodinated to Ts or rT3. It appears that monodeiodination may be an obligatory step in deiodination of T4.
Recent studies indicate that serum rTs is increased in several situations, e.g., hepatic cirrhosis, chronic renal failure, acute febrile illness, protein-calorie malnutrition (9) , and starvation (2) where serum T3 is decreased. In this study, MCR and PR of various iodothyronines were examined in one of these conditions, i.e. hepatic cirrhosis. The findings reflect several important alterations in iodothyronine metabolism in this disease. Thus, the data suggest that increase in serum rT3 in hepatic cirrhosis must be influenced importantly by the decrease in MCR of rTs (Table II) ; the mean daily PRrTs was similar to that in normal subjects. However, the daily production of rT3 relative to T4 was high in some cases (Fig. 2) . This was the case because PR-T4 was low. Others have also observed low normal or low in hepatic cirrhosis patients studied here. As against PR-rT3, PR-T3 in patients with hepatic cirrhosis was clearly subnormal; another recent study has also described low PR-T3 in hepatic cirrhosis (25) . PR-T3 was low in patients in this study whether it was examined as such (Table II) or in relation to PR-T4 (Fig. 2) . The distinctive change in PR-T3 compared to PR-rT3 was clearly evident when the ratio of PR-rTs to PR-T3 was examined. Thus, it was clear that production of rT3 relative to T3 is increased markedly in hepatic cirrhosis (Fig. 2) . Since most of T3 as well as rT3 originate from peripheral metabolism of T4, the present study suggests that the pattern of monodeiodination is so altered in hepatic cirrhosis that conversion of T4 to T3 is decreased, while that to rT3 is maintained normal or is increased. Similar situation has also been observed in normal fetus in whom serum T3 is less than, and serum rT3 is much higher than the adult levels (8) . These observations suggest the possibility that alterations in monodeiodination of T4 observed in hepatic cirrhosis and the fetus may also be the explanation in other situations where serum T3 is low and rTs is high (9, 36, 38) .
The routes of metabolism of T4 appear to be somewhat different in patients with hepatic cirrhosis than in normal subjects. Thus (34) , it seems possible that in addition to the above-mentioned abnormalities in T4 metabolism, the pathway of conversion of T4 to tetraiodothyroacetic acid or another side chain derivative of T4 may be accelerated in a systemic illness such as hepatic cirrhosis.
The mechanism responsible for the abnormalities in T4 metabolism in hepatic cirrhosis is unclear. This information would probably become available after the mechanisms of conversion of T4 to T3 and to rTs and other derivatives have been elucidated. Meanwhile, it is interesting to note that serum rT3 as well as T3 return to or towards normal after refeeding of patients with protein-calorie malnutrition (9) and starvation (2) . Improvement in low serum T3 has also been observed after recovery of liver function in patients with alcoholic hepatitis (25) . These findings suggests that the abnormality of T4 metabolism in illness and starvation is frequently reversible.
The biological purpose, if any, of the alteration in iodothyronine metabolism in hepatic cirrhosis is not clear at this time. It seems possible, however, that the apparent shunting of T4 from conversion to highly potent T3 (39) to the production of calorigenically inactive rT3 (40, 41) or other metabolites of T4 such as tetraiodothyroacetic acid (34, 42) may reflect a defense reaction of the body intended to safeguard against excessive metabolic stimulation during illness. Obviously, much further study will be needed before this or an alternative possibility can be established.
